THERAPEUTIC FOCUS
RESEARCH & DEVELOPMENT
Shareholder Tools
Briefcase Printed Materials Email Alerts Download Center snapshot RSS

Press Releases

The press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Amarin disavows any obligation to update the information contained in such press releases after the date of their issuance.

All Releases
View Summary Amarin Announces Encore Presentation of Results of the Apolipoprotein C-III Post-Hoc Analysis From MARINE and ANCHOR Studies of Vascepa(R) at the European Society of Cardiology (ESC) 2015 Annual Congress
27 Aug 2015
PDF 62.1 KB Add to Briefcase
View Summary Amarin Promotes Joseph T. Kennedy to Executive Vice President, General Counsel and Strategic Initiatives
11 Aug 2015
PDF 14.2 KB Add to Briefcase
View Summary First Amendment Decision a Win for Amarin and Physician Plaintiffs
7 Aug 2015
PDF 73.7 KB Add to Briefcase
View Summary Amarin Reports Second Quarter 2015 Financial Results and Provides Update on Operations
6 Aug 2015
PDF 94.7 KB Add to Briefcase
View Summary Amarin Announces Upcoming Presentations of Two Eicosapentaenoic Acid (EPA) Studies at the American Society for Preventive Cardiology (ASPC) Annual Cardiovascular Disease Prevention Conference and the Kern Lipid Conference
31 Jul 2015
PDF 62.8 KB Add to Briefcase
View Summary Amarin to Report Second Quarter 2015 Results and Host Conference Call on August 6, 2015
30 Jul 2015
PDF 12.1 KB Add to Briefcase
View Summary New In Vitro Eicosapentaenoic Acid Study Data to Be Presented at the National Lipid Association Scientific Sessions in Chicago
11 Jun 2015
PDF 12.3 KB Add to Briefcase
View Summary New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association Scientific Sessions in Boston
8 Jun 2015
PDF 12.2 KB Add to Briefcase
View Summary Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa(R) (Icosapent Ethyl) Capsules
28 May 2015
PDF 59.3 KB Add to Briefcase
View Summary Amarin to Present at the Jefferies 2015 Global Healthcare Conference
26 May 2015
PDF 10.3 KB Add to Briefcase
View Summary Amarin Reports First Quarter 2015 Financial Results and Provides Update on Operations
8 May 2015
PDF 87.8 KB Add to Briefcase
View Summary Amarin to Report First Quarter 2015 Results and Host Conference Call on May 8, 2015
5 May 2015
PDF 11.7 KB Add to Briefcase
View Summary Amarin and Non-Profit, Walk with a Doc Partner to Expand National Health Awareness Efforts
8 Apr 2015
PDF 57.7 KB Add to Briefcase
View Summary New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty Acid EPA Pre-Treatment Reduces Oxidative Damage and May Provide Atheroprotective Benefit Versus Other Triglyceride Lowering Agents
16 Mar 2015
PDF 15.8 KB Add to Briefcase
View Summary Amarin Announces $52.8 Million Private Placement
6 Mar 2015
PDF 13.2 KB Add to Briefcase
View Summary New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid EPA and Atorvastatin May Provide Atheroprotective Benefit
4 Mar 2015
PDF 51.3 KB Add to Briefcase
View Summary Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations
3 Mar 2015
PDF 97.5 KB Add to Briefcase
View Summary Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on Tuesday, March 3, 2015
2 Mar 2015
PDF 10.4 KB Add to Briefcase
View Summary Amarin and Eddingpharm Announce Agreement to Develop and Commercialize Vascepa(R) (icosapent ethyl) in China
26 Feb 2015
PDF 69.0 KB Add to Briefcase
View Summary Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015
23 Feb 2015
PDF 11.8 KB Add to Briefcase
Showing 1-20 of 231 Page: 1 2 3 4 5 ... 12  Next 20
Add to Briefcase = add release to Briefcase